Search - tctmd.com

Displaying 321 - 340 of 1179

Sort: Relevancy | Date

News Daily News

研究认为有数据支持针对患者风险而非 LDL 胆固醇目标进行治疗

Michael O'Riordan

February 15, 2016

News Daily News

Según un Informe los Datos Avalan Tratar el Riesgo de los Pacientes No las Dianas de Colesterol LBD

Michael O'Riordan

February 15, 2016

News Daily News

Data Support Treating Patient Risk, Not LDL Cholesterol Targets, Paper Argues

Michael O'Riordan

February 15, 2016

Presentation JIM 2016

Medical therapy optimization with new anti-ischemic drugs

Presenter: Giuseppe Musumeci

February 11, 2016

Presentation JIM 2016

Clinical Case: High risk ACS

Presenter: Giuseppe Tarantini

February 11, 2016

News Daily News

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

L.A. McKeown

February 09, 2016

News Daily News

Statins Possibly Protect Against Death, CV Events in Asymptomatic PAD Patients

Caitlin E. Cox

February 08, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

February 08, 2016

News Daily News

Complex Lesions, Thrombus During PCI May Spell Trouble After DES Implantation

Todd Neale

February 07, 2016

News Daily News

ROCKET AF Investigators: Problems With Warfarin Monitoring Device Did Not Skew Results

Todd Neale

February 04, 2016

News Daily News

Signs of Cardioprotection Seen in Acute STEMI Patients Receiving IV Beta-blocker Post-PCI

Caitlin E. Cox

February 03, 2016

News Daily News

Se Observan Signos de Cardioprotección en Pacientes STEMI Agudos que Reciben Beta-Bloqueadores Post-PCI

Caitlin E. Cox

February 03, 2016

News Daily News

PCI 后接受 IV β 受体阻滞剂的急性 STEMI 患者中观察到心肌保护迹象

Caitlin E. Cox

February 03, 2016

Presentation

BEAT-AMI: Randomized Control of Sympathetic Drive With Continuous IV Esmolol in Patients With Acute STEMI

Presenter: Fikret Er

February 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2016

Shelley Wood

February 01, 2016

News Featured Fellow

J. Raider Estrada, MD

Yael L. Maxwell

January 31, 2016

News Daily News

在他汀类药物治疗基础上添加依泽替米贝可以降低首次和后续心血管事件的风险：IMPROVE-IT 分析

Michael O'Riordan

January 26, 2016

News Daily News

Análisis del IMPROVE-IT: La Incorporación de Ezetimibe al Tratamiento con Estatinas Reduce el Riesgo de Sufrir Primeros y Subsiguientes Episodios CV

Michael O'Riordan

January 26, 2016

News Daily News

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

Michael O'Riordan

January 26, 2016

News Daily News

Califf’s Road to FDA Gets Rockier as Senators Place Holds on Process

Shelley Wood

January 26, 2016

Advertisement

研究认为有数据支持针对患者风险而非 LDL 胆固醇目标进行治疗

Según un Informe los Datos Avalan Tratar el Riesgo de los Pacientes No las Dianas de Colesterol LBD

Data Support Treating Patient Risk, Not LDL Cholesterol Targets, Paper Argues

Medical therapy optimization with new anti-ischemic drugs

Clinical Case: High risk ACS

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

Statins Possibly Protect Against Death, CV Events in Asymptomatic PAD Patients

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

Complex Lesions, Thrombus During PCI May Spell Trouble After DES Implantation

ROCKET AF Investigators: Problems With Warfarin Monitoring Device Did Not Skew Results

Signs of Cardioprotection Seen in Acute STEMI Patients Receiving IV Beta-blocker Post-PCI

Se Observan Signos de Cardioprotección en Pacientes STEMI Agudos que Reciben Beta-Bloqueadores Post-PCI

PCI 后接受 IV β 受体阻滞剂的急性 STEMI 患者中观察到心肌保护迹象

BEAT-AMI: Randomized Control of Sympathetic Drive With Continuous IV Esmolol in Patients With Acute STEMI

TCTMD’s Top 10 Most Popular Stories for January 2016

J. Raider Estrada, MD

在他汀类药物治疗基础上添加依泽替米贝可以降低首次和后续心血管事件的风险：IMPROVE-IT 分析

Análisis del IMPROVE-IT: La Incorporación de Ezetimibe al Tratamiento con Estatinas Reduce el Riesgo de Sufrir Primeros y Subsiguientes Episodios CV

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

Califf’s Road to FDA Gets Rockier as Senators Place Holds on Process

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content